Quick Answer
ABVC BIOPHARMA, INC. reported Shares Outstanding of 25.05 million shares for fiscal year 2025.
ABVC BIOPHARMA, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 25.05M | +80.6% |
| 2024 | 13.87M | +74.7% |
| 2023 | 7.94M | +141.6% |
| 2022 | 3.29M | -86.5% |
| 2021 | 24.42M | +0.0% |
| 2020 | 24.42M | +25.4% |
| 2019 | 19.48M | +63.9% |
| 2018 | 11.88M | -94.4% |
| 2017 | 213.75M | +0.0% |
| 2017 | 213.75M | +1.4% |
| 2016 | 210.82M | +26.8% |
| 2015 | 166.27M | +1491948.8% |
| 2014 | 11,144 | -100.0% |
| 2013 | 54.59M | +285.6% |
| 2012 | 14.16M | +0.0% |
| 2011 | 14.16M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 24.19M | +90.3% | +23.8% |
| June 30, 2025 | 19.53M | +62.1% | +27.0% |
| March 31, 2025 | 15.38M | +43.7% | +10.9% |
| December 31, 2024 | 13.87M | +74.7% | +9.1% |
| September 30, 2024 | 12.71M | +163.6% | +5.5% |
| June 30, 2024 | 12.05M | +264.3% | +12.7% |
| March 31, 2024 | 10.70M | -67.7% | +34.7% |
| December 31, 2023 | 7.94M | +141.6% | +64.6% |
- ABVC BIOPHARMA, INC. showed an increase of +80.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, ABVC BIOPHARMA, INC.’s shares outstanding has grown by 76.9% (from 14.16 million shares to 25.05 million shares).
- The most recent figure is from ABVC BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: